Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank64
3Y CAGR-22.4%
5Y CAGR-2.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-22.4%/yr
Annual compound
5Y CAGR
-2.9%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$122.31M+25.1%
2024$97.73M-50.5%
2023$197.41M-24.5%
2022$261.44M+11.9%
2021$233.74M+64.7%
2020$141.90M+10.4%
2019$128.55M+189.0%
2018$-144.45M-336.2%
2017$-33.12M-5.8%
2016$-31.30M-